HALOPERIDOL LACTATE

Post-LOE

haloperidol lactate

Teva

ANDAORALSOLUTION

Approved

Nov 1995

Lifecycle

Post-LOE

Competitive Pressure

30/100

Data completeness

3/8 — Basic

HALOPERIDOL LACTATE (haloperidol lactate) by Teva is clinical pharmacology haloperidol is an antipsychotic. Approved for schizophrenia. First approved in 1995.

Drug data last refreshed 20h ago

Mechanism of Action

CLINICAL PHARMACOLOGY Haloperidol is an antipsychotic. The mechanism of action of haloperidol for the treatment of schizophrenia is unclear. However, its efficacy could be mediated through its activity as an antagonist at central dopamine type 2 receptors. Haloperidol also binds to alpha-1…

Indications (1)

schizophrenia

Company

Worked on HALOPERIDOL LACTATE at Teva? Share your interview experience or compensation data (+7 days Pro)

Data Sources

Drug label: DailyMed / FDA
Clinical trials: ClinicalTrials.gov
Patent data: FDA Orange Book
Spending data: CMS Medicare

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.